Deutsch English Français

Contact

EP2419509

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2419509

EP2419509 - DEVELOPMENT OF FLUORESCENTLY P-LOOP LABELLED KINASES FOR SCREENING OF INHIBITORS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 02.05.2014 Database last updated on 19.10.2024
Most recent event Tooltip	02.05.2014	Application deemed to be withdrawn	published on 04.06.2014 [2014/23]
Applicant(s)	For all designated states Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Hofgartenstrasse 8 80539 München / DE
	[N/P]
Former [2012/08]	For all designated states Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Hofgartenstrasse 8 80539 München / DE
Former [N/P]	For all designated states Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Hofgartenstra e 8 80539 München / DE
Inventor(s)	01 / RAUH, Daniel Wasserturmstrasse 16 67549 Worms / DE
	02 / SIMARD, Jeffrey, Raymond 37 Hillside Avenue Salem MA 01970 / US
	[2012/08]
Representative(s)	Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
	[N/P]
Former [2012/08]	Vossius & Partner Siebertstrasse 4 81675 München / DE
Application number, filing date	10714279.6	19.04.2010
	WO2010EP55129
Priority number, date	EP20090005492	17.04.2009 Original published format: EP 09005492
	US20090170375P	17.04.2009 Original published format: US 170375 P
	[2012/08]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2010119138
	Date:	21.10.2010
	Language:	EN
	[2010/42]
	Type:	A1 Application with search report
	No.:	EP2419509
	Date:	22.02.2012
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 21.10.2010 takes the place of the publication of the European patent application.
	[2012/08]
Search report(s)	International search report - published on:	EP	21.10.2010
Classification	IPC:	C12N9/16, C12Q1/48	[2012/08]
	CPC:	C12N9/12 (EP,US); C12Q1/485 (EP,US); G01N33/531 (EP,US); G01N2500/00 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/08]
Title	German:	ENTWICKLUNG VON MIT P-SCHLEIFE FLUORESZENT MARKIERTEN KINASEN FÜR DAS SCREENING VON HEMMERN	[2013/27]
	English:	DEVELOPMENT OF FLUORESCENTLY P-LOOP LABELLED KINASES FOR SCREENING OF INHIBITORS	[2012/08]
	French:	Développement de kinases étiquetées P-loop à fluorescence pour le criblage des inhibiteurs	[2013/27]
	Former [2012/08]	ENTWICKLUNG VON P-LOOP-FLUORESZENZMARKIERTEN KINASEN ZUM SCREENING VON INHIBITOREN
	Former [2012/08]	DÉVELOPPEMENT DE KINASES MARQUÉES EN BOUCLE P PAR FLUORESCENCE POUR UN CRIBLAGE D'INHIBITEURS
Entry into regional phase	15.11.2011	National basic fee paid
	15.11.2011	Designation fee(s) paid
	15.11.2011	Examination fee paid
Examination procedure	17.11.2011	Examination requested [2012/08]
	31.05.2012	Amendment by applicant (claims and/or description)
	22.08.2012	Despatch of a communication from the examining division (Time limit: M02)
	09.10.2012	Reply to a communication from the examining division
	04.02.2013	Despatch of a communication from the examining division (Time limit: M02)
	12.04.2013	Reply to a communication from the examining division
	02.08.2013	Communication of intention to grant the patent
	13.12.2013	Application deemed to be withdrawn, date of legal effect [2014/23]
	20.01.2014	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2014/23]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.08.2012
Fees paid	Renewal fee
	27.03.2012	Renewal fee patent year 03
	23.04.2013	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X] - LANGER THOMAS ET AL, "NMR backbone assignment of a protein kinase catalytic domain by a combination of several approaches: application to the catalytic subunit of cAMP-dependent protein kinase", CHEMBIOCHEM - A EUROPEAN JOURNAL OF CHEMICAL BIOLOGY, WILEY VCH, WEINHEIM, DE, (20041105), vol. 5, no. 11, ISSN 1439-4227, pages 1508 - 1516, XP002503169 [X] 1-4,9,11,13 * abstract * DOI: http://dx.doi.org/10.1002/CBIC.200400129
		[X] - JOSEPH R. LAKOWICZ, Principles of fluorescence spectroscopy, SPRINGER, (2006), ISBN 0387312781, XP000918225 [X] 1-4 * see section 13.5.3 wherein alexa 546 labeled kinase is mentionned; page 459 *
		[X] - LEVINE H III ET AL, "A MONOCLONAL ANTIBODY AGAINST BRAIN CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II DETECTS PUTATIVE CONFORMATION CHANGES INDUCED BY CALCIUM CALMODULIN", BIOCHEMISTRY, (1988), vol. 27, no. 17, ISSN 0006-2960, pages 6612 - 6617, XP002540825 [X] 1-4 * abstract * DOI: http://dx.doi.org/10.1021/bi00417a060
		[X] - FIRST E A ET AL, "SELECTIVE MODIFICATION OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE WITH SULFHYDRYL-SPECIFIC FLUORESCENT PROBES", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, EASTON, PA.; US, (19890101), vol. 28, no. 8, ISSN 0006-2960, pages 3598 - 3605, XP002073139 [X] 1-4 * abstract * DOI: http://dx.doi.org/10.1021/bi00434a067
		[A] - KAPAHI PANKAJ ET AL, "Inhibition of NF-kappaB activation by arsenite through reaction with a critical cysteine in the activation loop of IkappaB kinase", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM, US, vol. 275, no. 46, ISSN 0021-9258, (20001101), pages 36062 - 36066, (20000830), XP002503167 [A] 1-17 * page 36065, column 1, paragraph 2; figure 4 * DOI: http://dx.doi.org/10.1074/JBC.M007204200
	by applicant	- HOLZGRABE; BECHTOLD, DEUTSCHE APOTHEKER ZEITUNG, (2000), vol. 140, no. 8, pages 813 - 823
		- ADRIAN, F. J.; DING, Q.; SIN, T.; VELENTZA, A.; SLOAN, C.; LIU, Y.; ZHANG, G.; HUR, W.; DING, S.; MANLEY, P., NAT CHEM BIOL, (2006), vol. 2, pages 95 - 102
		- ANNIS, D. A.; NAZEF, N.; CHUANG, C. C.; SCOTT, M. P.; NASH, H. M., "A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (2004), vol. 126, pages 15495 - 15503
		- R. T. AIMES; W. HEMMER; S. S. TAYLOR, "Serine-53 at the tip of the glycine-rich loop of cAMP- dependent protein kinase: role in catalysis, P-site specificity, and interaction with inhibitors", BIOCHEMISTRY, (2000), vol. 39, page 8325
		- B. APSEL; J. A. BLAIR; B. GONZALEZ; T. M. NAZIF; M. E. FELDMAN; B. AIZENSTEIN; R. HOFFMAN; R. L. WILLIAMS; K. M. SHOKAT; Z. A. KNI, NAT CHEM BIOL, (2008), vol. 4, page 691
		- C. BACKES; B. ZECH; B. FELBER; B. KLEBL; G. MU))ER, EXPERT OPIN DRUG DISCOVERY, (2008), vol. 3, page 1409
		- C. BACKES; B. ZECH; B. FELBER; B. KLEBL; G. MüLLER, EXPERT OPIN DRUG DISCOVERY, (2008), vol. 3, page 1427
		- BEEBE, J. S.; JANI, J. P.; KNAUTH, E.; GOODWIN, P.; HIGDON, C.; ROSSI, A. M.; EMERSON, E.; FINKELSTEIN, M.; FLOYD, E.; HARRIMAN, S, "Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy", CANCER RES, (2003), vol. 63, pages 7301 - 9
		- J. A. BLAIR; D. RAUH; C. KUNG; C. H. YUN; Q. W. FAN; H. RODE; C. ZHANG; M. J. ECK; W. A. WEISS; K. M. SHOKAT, NAT CHEM BIOL, (2007), vol. 3, page 229
		- CALLEJA, V.; LAGUERRE, M.; PARKER, P. J.; LARIJANI, B., PLOS BIOL, (2009), vol. 7, pages 189 - 200
		- R. A. COPELAND; D. L. POMPLIANO; T. D. MEEK, NAT REV DRUG DISCOV, (2006), vol. 5, page 730
		- DAR, A. C.; LOPEZ, M. S.; SHOKAT, K. M., "Small Molecule Recognition of c-Src via the lmatinib-Binding Conformation", CHEM BIOL, (2008), vol. 15, no. 10, page 1015
		- DELANO, W.L., THE PYMOL MOLECULAR GRAPHICS SYSTEM, (2002), URL: www.pymol.org
		- LORIMIER, R. M.; SMITH, J. J.; DWYER, M. A.; LOOGER, L. L.; SALI, K. M.; PAAVOLA, C. D.; RIZK, S. S.; SADIGOV, S.; CONRAD, D. W.;, "Construction of a fluorescent biosensor family", PROTEIN SCI, (2002), vol. 11, pages 2655 - 2675
		- DUMAS, J.; HATOUM-MOKDAD, H.; SIBLEY, R.; RIEDL, B.; SCOTT, W. J.; MONAHAN, M. K.; LOWINGER, T. B.; BRENNAN, C.; NATERO, R.; TURNE, "1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2000), vol. 10, pages 2051 - 2054
		- EMSLEY, P.; COWTAN, K., "Coot: model-building tools for molecular graphics", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, (2004), vol. 60, page 2126
		- EYERS, P. A.; CHURCHILL, M. E.; MALLER, J. L., "The Aurora A and Aurora B protein kinases: a single amino acid difference controls intrinsic activity and activation by TPX2", CELL CYCLE, (2005), vol. 4, pages 784 - 9
		- M. J. GARNETT; R. MARAIS, CANCER CELL, (2004), vol. 6, page 313
		- GETLIK, M.; GRUTTER, C.; SIMARD, J. R.; KLUTER, S.; RABILLER, M.; RODE, H. B.; ROBUBI, A.; RAUH, D., "Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc", J MED CHEM, (2009), vol. 52, pages 3915 - 26
		- GSCHWIND, A.; FISCHER, O. M.; ULLRICH, A., "The discovery of receptor tyrosine kinases: targets for cancer therapy", NAT REV CANCER, (2004), vol. 4, no. 5, page 361
		- S. K. HANKS; T. HUNTER, FASEB J, (1995), vol. 9, page 576
		- HIBBS, R. E.; TALLEY, T. T.; TAYLOR, P., "Acrylodan-conjugated cysteine side chains reveal conformational state and ligand site locations of the acetylcholine-binding protein", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2004), vol. 279, pages 28483 - 28491
		- JOHNSON, L. N.; NOBLE, M. E. M.; OWEN, D. J., "Active and inactive protein kinases : structural basis for regulation", CELL, (1996), vol. 85, pages 149 - 158
		- JOHNSON, L. N.; LEWIS, R. E., "Structural basis for control by phosphorylation", CHEM REV., (200108), vol. 101, no. 8, pages 2209 - 42
		- KABSCH, W., "Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants", J. APPL. CRYST., (1993), vol. 26, page 795
		- KARAMAN, M. W.; HERRGARD, S.; TREIBER, D. K.; GALLANT, P.; ATTERIDGE, C. E.; CAMPBELL, B. T.; CHAN, K. W.; CICERI, P.; DAVIS, M. I, "A quantitative analysis of kinase inhibitor selectivity", NAT BIOTECHNOL, (2008), vol. 26, pages 127 - 32
		- KNIGHTON, D. R.; ZHENG, J. H.; TEN EYCK, L. F.; XUONG, N. H; TAYLOR, S. S.; SOWADSKI, J. M., "Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase", SCIENCE, (1991), vol. 253, pages 414 - 20
		- LAFONT, V.; ARMSTRONG, A. A.; OHTAKA, H.; KISO, Y.; MARIO AMZEL, L.; FREIRE, E., CHEM BIOL DRUG DES, (2007), vol. 69, pages 413 - 22
		- LASKOWSKI, R. A.; MACARTHUR, M. W.; MOSS, D. S.; THORNTON, J. M., "PROCHECK: a program to check the stereochemical quality of protein structures", J APPL CRYST, (1993), vol. 26, page 283
		- LARKIN, M. A. ET AL., "Clustal W and Clustal X version 2.0", BIOINFORMATICS, (2007), vol. 23, no. 21, page 2947
		- LEVINSON, N. M. ET AL., "A Src-like inactive conformation in the abl tyrosine kinase domain", PLOS BIOL, (2006), vol. 4, no. 5, page 144
		- LIU, Y.; GRAY, N. S., "Rational design of inhibitors that bind to inactive kinase conformation", NAT CHEM BIOL, (2006), vol. 2, no. 7, page 358
		- LIU, C. C.; SCHULTZ, P. G., "Adding new chemistries to the genetic code", ANNU REV BIOCHEM, (2010), vol. 79, pages 15.1 - 15.32
		- M. MAPELLI; L. MASSIMILIANO; C. CROVACE; M. A. SEELIGER; L. H. TSAI; L. MEIJER; A. MUSACCHIO, J MED CHEM, (2005), vol. 48, page 671
		- MICHALCZYK, A. ET AL., "Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR", BIOORG MED CHEM, (2008), vol. 16, no. 7, page 3482
		- MURALI DHAR, T. G.; WROBLESKI, S. T.; LIN, S.; FURCH, J. A.; NIRSCHL, D. S.; FAN, Y.; TODDERUF, G.; PITT, S.; DOWEYKO, A. M.; SACK, "Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicydic scaffolds", BIOORG MED CHEM LETT, (2007), vol. 17, pages 5019 - 24
		- MURSHUDOV, G. N.; VAGIN, A. A.; DODSON, E. J., "Refinement of macromolecular structures by the maximum-likelihood method", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, (1997), vol. 53, page 240
		- B. NAGAR; W. G. BORNMANN; P. PELLICENA; T. SCHINDLER; D. R. VEACH; W. T. MILLER; B. CLARKSON; J. KURIYAN, CANCER RES, (2002), vol. 62, page 4236
		- NIENABER, V. L. ET AL., "Discovering novel ligands for macromolecules using X-ray crystallographic screening", NATURE BIOTECHNOLOGY, (2000), vol. 18, no. 10, page 1105
		- PARGELLIS, C.; TONG, L.; CHURCHILL, L.; CIRILLO, P. F.; GILMORE, T.; GRAHAM, A. G.; GROB, P. M.; HICKEY, E. R.; MOSS, N.; PAV, S., "Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site", NATURE STRUCTURAL BIOLOGY, (2002), vol. 9, pages 268 - 272
		- PATEL, S. B.; CAMERON, P. M.; O'KEEFE, S. J.; FRANTZ-WATTLEY, B.; THOMPSON, J.; O'NEILL, E. A.; TENNIS, T.; LIU, L.; BECKER, J. W., ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, (2009), vol. 65, pages 777 - 85
		- PAWAR, V. G.; SOS, M. L.; RODE, H. B.; RABILLER, M.; HEYNCK, S.; VAN OTTERLO, W. A. L.; THOMAS, R. K.; RAUH, D., "Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor", J MED CHEM, (2010), vol. 53, no. 7, pages 2892 - 901
		- "Rapid and Sensitive Sequence Comparison with FASTP and FASTA", W. A PEARSON, Methods in Enzymology, ACADEMIC PRESS, (1990), vol. 183, pages 63 - 98
		- PIERCE AC; HAAR E; BINCH HM; KAY DP; PATEL SR; LI P, J MED CHEM., (20050224), vol. 48, no. 4, pages 1278 - 81
		- READ, R. J., "Pushing the boundaries of molecular replacement with maximum likelihood", ACTA CRYSTALLOGR D, (2001), vol. 57, page 1373
		- REICH, M. ET AL., "GenePattern 2.0", NAT GENET, (2006), vol. 38, no. 5, page 500
		- REGAN, J.; BREITFELDER, S.; CIRILLO, P.; GILMORE, T.; GRAHAM, A. G.; HICKEY, E.; KLAUS, B.; MADWED, J.; MORIAK, M.; MOSS, N., "Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate", JOURNAL OF MEDICINAL CHEMISTRY, (2002), vol. 45, pages 2994 - 3008
		- REGAN, J.; PARGELLIS, C. A.; CIRILLO, P. F.; GILMORE, T.; HICKEY, E. R.; PEET, G. W.; PROTO, A.; SWINAMER, A.; MOSS, N., "The kinetics of binding to p38MAP kinase by analogues of BIRB 796", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2003), vol. 13, pages 3101 - 3104
		- RICHIERI, G. V.; OGATA, R. T.; KLEINFELD, A. M., "The measurement of free fatty acid concentration with the fluorescent probe ADIFAB: a practical guide for the use of the ADIFAB probe", MOLECULAR AND CELLULAR BIOCHEMISTRY, (1999), vol. 192, pages 87 - 94
		- M. SARASTE; P. R. SIBBALD; A. WITTINGHOFER, TRENDS BIOCHEM SCI, (1990), vol. 15, page 430
		- SCHUTTELKOPF, A. W.; VAN AALTEN, D. M., "PRODRG: a tool for high-throughput crystallography of protein-ligand complexes", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, (2004), vol. 60, page 1355
		- SULLIVAN, J. E.; HOLDGATE, G. A.; CAMPBELL, D.; TIMMS, D.; GERHARDT, S.; BREED, J.; BREEZE, A. L.; BERMINGHAM, A.; PAUPTIT, R. A.;, "Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase", BIOCHEMISTRY, (2005), vol. 44, pages 16475 - 16490
		- M. A. SEELIGER; B. NAGAR; F. FRANK; X. CAO; M. N. HENDERSON; J. KURIYAN, STRUCTURE, (2007), vol. 15, page 299
		- SHUKER, S. B.; HAJDUK, P. J.; MEADOWS, R. P.; FESIK, S. W., "Discovering high-affinity ligands for proteins: SAR by NMR", SCIENCE, (1996), vol. 274, no. 5292, page 1531
		- J. R. SIMARD; S. KLUTER; C. GRüTTER; M. GETLIK; M. RABILLER; H. B. RODE; D. RAUH, NAT CHEM BIOL, (2009), vol. 5, pages 394 - 396
		- SIMARD, J. R.; GETLIK, M.; GRUTTER, C.; PAWAR, V.; WULFERT, S.; RABILLER, M.; RAUH, D., "Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors", J AM CHEM SOC, (2009), vol. 131, pages 13286 - 13296
		- SOS, M. L.; RODE, H. B.; HEYNCK, S.; PEIFER, M.; FISCHER, F.; KIUTER, S.; PAWAR, V. G.; REUTER, C.; HEUCKMANN, J.; WEISS, J., "Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation", CANCER RESEARCH, (2010), vol. 70, no. 3, pages 868 - 74
		- TAMAYO, N; LIAO, L.; GOLDBERG,M.; POWERS, D.; TUDOR, Y-Y; YU, V.; WONG, L. M.; HENKLE, B.; MIDDLETON, S.; SYED, R., "Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2005), vol. 15, pages 2409 - 2413
		- TECLE, H.; FERU, F.; LIU, H.; KUHN, C.; RENNIE, G.; MORRIS, M.; SHAO, J.; CHENG, A. C.; GIKUNJU, D.; MIRET, J., "The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assay", CHEM BIOL, (2009), vol. 74, pages 547 - 59
		- TAYLOR, S. S.; RADZIO-ANDZELM, E., "Three protein kinase structures define a common motif", STRUCTURE, (1994), vol. 2, pages 345 - 355
		- VOGTHERR, M.; SAXENA, K.; HOELDER, S.; GRIMME, S.; BETZ, M.; SCHIEBORR, U.; PESCATORE, B.; ROBIN, M.; DELARBRE, L.; LANGER, T., "NMR characterization of kinase p38 dynamics in free and ligand- bound forms", ANGEWANDTE CHEMIE, (2006), vol. 45, pages 993 - 997
		- YEATMAN, T. J., "A renaissance for SRC", NAT REV CANCER, (2004), vol. 4, no. 6, page 470
		- TOKARSKI, J.S.; NEWITT, J.; CHANG, C.Y.J.; CHENG, J.D.; WITTEKIND, M.; KIEFER, S.E.; KISH, K.; LEE, F.Y.F.; BORZILERRI, R.; LOMBAR, CANCER RES., (2006), vol. 66, pages 5790 - 5797
		- WAN, P. T.; GARNETT, M. J.; ROE, S. M.; LEE, S.; NICULESCU-DUVAZ, D.; GOOD, V. M.; JONES, C. M.; MARSHALL, C. J.; SPRINGER, C. J.;, CELL, (2004), vol. 116, page 855
	- WANG, X; DESTRUMENT, A; TOURNIER, C, "Physiological roles of MKK4 and MKK7: Insights from animal models", BIOCHIMICA ET BIOPHYSICA ACTA, (2007), vol. 1773, pages 1349 - 1357
	- WONG, L.; LIESER, S. A.; MIYASHITA, O.; MILLER, M.; TASKEN, K.; ONUCHIC, J. N.; ADAMS, J. A.; V. L. WOODS; JR.; P. A. JENNINGS, J MOL BIOL, (2005), vol. 351, page 131
	- YEM, A. W.; EPPS, D. E.; MATHEWS, W. R.; GUIDO, D. M.; RICHARD, K. A.; STAITE, N. D.; DEIBEL, M. R., JR., "Site-specific chemical modification of interleukin-1 beta by acrylodan at cysteine 8 and lysine 103", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1992), vol. 267, pages 3122 - 3128
	- J. ZHANG; P. L. YANG; N. S. GRAY, NAT. REV. CANCER, (2009), vol. 9, page 28
	EP20080013340
	EP20080020341

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p